The Evolving Role of Genetic Testing in Monogenic Kidney Stone Disease: Spotlight on Primary Hyperoxaluria
Authors:
- 1 November 2024
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 212 (5) , 649-659
Abstract
Multiple factors are thought to give rise to common, recurrent kidney stone disease, but for monogenic stone disorders a firm diagnosis is possible through genetic testing. The autosomal recessive primary hyperoxalurias (PH) are rare but important forms of monogenic kidney stone disease. All 3 types of PH are caused by inborn errors of glyoxylate metabolism in the liver, leading to hepatic oxalate overproduction and excessive renal urinary oxalate excretion. The conditions are characterized by kidney stones, nephrocalcinosis, progressive chronic kidney disease (CKD), and eventually kidney failure. Systemic oxalosis, the extra-renal deposition of oxalate resulting in severe morbidity and mortality, occurs in the setting of CKD when oxalate clearance by the kidneys declines. Novel small interfering RNA-based therapeutics targeting the liver to reduce urinary oxalate excretion have been approved, introducing precision medicine to treat primary hyperoxaluria type 1 (PH1). Increased access to genetic testing facilitates early detection of PH and other monogenic causes of kidney stone disease so that individualized care can be instituted promptly. This narrative review addresses the benefits and practicalities of genetic testing for suspected monogenic kidney stone disease and the critical roles of a multidisciplinary team. We share our procedures, education, training, and workflows to help other clinicians integrate genetic assessment into their diagnostic routines. This information may ensure more timely diagnoses so that patients with suspected monogenic kidney stone disease gain access to an expanded range of services and enrollment in clinical trials and registries.Keywords
Funding Information
- Dicerna Pharmaceuticals, Inc., a Novo Nordisk Company
This publication has 43 references indexed in Scilit:
- Distinguishing characteristics of pediatric patients with primary hyperoxaluria type 1 in PEDSnetJournal of Pediatric Urology, 2023
- Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)Urolithiasis, 2023
- Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone DiseaseKidney International Reports, 2021
- Urine and stone analysis for the investigation of the renal stone former: a consensus conferenceUrolithiasis, 2020
- Plasma oxalate: comparison of methodologiesUrolithiasis, 2020
- Recent advances in the identification and management of inherited hyperoxaluriasUrolithiasis, 2018
- The primary hyperoxalurias: A practical approach to diagnosis and treatmentInternational Journal of Surgery, 2016
- Renal function can be impaired in children with primary hyperoxaluria type 3Pediatric Nephrology, 2015
- Medical Management of Kidney Stones: AUA GuidelineJournal of Urology, 2014
- Hereditary causes of kidney stones and chronic kidney diseasePediatric Nephrology, 2013